{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:18:30Z","timestamp":1791317910063,"version":"4.3.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jacep.2024.12.013","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T14:21:45Z","timestamp":1739370105000},"page":"977-986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Causal Machine Learning for Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation"],"prefix":"10.1016","volume":"11","author":[{"given":"Che","family":"Ngufor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly K.","family":"Van Houten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"David R.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Graff-Radford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Alkhouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Noseworthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jacep.2024.12.013_bib1","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death the Framingham Heart Study","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.jacep.2024.12.013_bib2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jacep.2024.12.013_bib3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jacep.2024.12.013_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/jamacardio.2015.0374","article-title":"Oral anticoagulant therapy prescription in patients with atrial fibrillation across the spectrum of stroke risk: insights from the NCDR PINNACLE Registry","volume":"1","author":"Hsu","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"21","key":"10.1016\/j.jacep.2024.12.013_bib5","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1161\/CIRCULATIONAHA.106.653048","article-title":"Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation","volume":"115","author":"Hylek","year":"2007","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jacep.2024.12.013_bib6","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.003074","article-title":"Effect of adherence to oral anticoagulants on risk of stroke and major bleeding among patients with atrial fibrillation","volume":"5","author":"Yao","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.jacep.2024.12.013_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2021.10.023","article-title":"4-Year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation","volume":"79","author":"Osmancik","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.jacep.2024.12.013_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.027001","article-title":"Percutaneous left atrial appendage occlusion in comparison to non-vitamin K antagonist oral anticoagulant among patients with atrial fibrillation","volume":"11","author":"Noseworthy","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.jacep.2024.12.013_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcin.2020.09.051","article-title":"Clinical outcomes associated with left atrial appendage occlusion versus direct oral anticoagulation in atrial fibrillation","volume":"14","author":"Nielsen-Kudsk","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacep.2024.12.013_bib10","article-title":"Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects","volume":"363","author":"Kent","year":"2018","journal-title":"BMJ (Clin Res Ed)"},{"issue":"1","key":"10.1016\/j.jacep.2024.12.013_bib11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/jech.2010.121095","article-title":"Damned if you do, damned if you don't: subgroup analysis and equity","volume":"66","author":"Petticrew","year":"2012","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.jacep.2024.12.013_bib12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ahj.2023.02.015","article-title":"Identifying treatment heterogeneity in atrial fibrillation using a novel causal machine learning method","volume":"260","author":"Ngufor","year":"2023","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.jacep.2024.12.013_bib13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1017\/pan.2018.46","article-title":"How much should we trust estimates from multiplicative interaction models? Simple tools to improve empirical practice","volume":"27","author":"Hainmueller","year":"2019","journal-title":"Political Analysis"},{"issue":"7","key":"10.1016\/j.jacep.2024.12.013_bib14","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1377\/hlthaff.2014.0038","article-title":"Optum Labs: building a novel node in the learning health care system","volume":"33","author":"Wallace","year":"2014","journal-title":"Health Aff"},{"issue":"11","key":"10.1016\/j.jacep.2024.12.013_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.25505","article-title":"assessment of trends in statin therapy for secondary prevention of atherosclerotic cardiovascular disease in US adults from 2007 to 2016","volume":"3","author":"Yao","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.jacep.2024.12.013_bib16","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1200\/JCO.2014.58.3062","article-title":"Household net worth, racial disparities, and hormonal therapy adherence among women with early-stage breast cancer","volume":"33","author":"Hershman","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jacep.2024.12.013_bib17","first-page":"14","article-title":"Using control groups to target on predicted lift: building and assessing uplift model","author":"Radcliffe","year":"2007","journal-title":"Direct Marketing Analytics Journal"},{"issue":"25","key":"10.1016\/j.jacep.2024.12.013_bib18","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"issue":"523","key":"10.1016\/j.jacep.2024.12.013_bib19","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1080\/01621459.2017.1319839","article-title":"Estimation and inference of heterogeneous treatment effects using random forests","volume":"113","author":"Wager","year":"2018","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.jacep.2024.12.013_bib20","article-title":"Generalized random forests","author":"Athey","year":"2019","journal-title":"arXiv:1610.01271 [stat.ME]"},{"key":"10.1016\/j.jacep.2024.12.013_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jeem.2020.102337","article-title":"Causal forest estimation of heterogeneous and time-varying environmental policy effects","volume":"103","author":"Miller","year":"2020","journal-title":"Journal of Environmental Economics and Management"},{"key":"10.1016\/j.jacep.2024.12.013_bib22","first-page":"1","article-title":"Causal inference and uplift modelling: a review of the literature","volume":"67","author":"Gutierrez","year":"2017","journal-title":"Proceedings of Machine Learning Research"},{"key":"10.1016\/j.jacep.2024.12.013_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.amjcard.2023.07.040","article-title":"Temporal changes in racial and ethnic disparities in the utilization of left atrial appendage occlusion in the United States","volume":"204","author":"Lopez","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacep.2024.12.013_bib24","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-Year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials","volume":"70","author":"Reddy","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jacep.2024.12.013_bib25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Joglar","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2024.12.013_bib26","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.121.057063","article-title":"Amplatzer Amulet left atrial appendage occluder versus watchman device for stroke prophylaxis (Amulet IDE): a randomized, controlled trial","volume":"144","author":"Lakkireddy","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2024.12.013_bib27","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026295","article-title":"Two-year outcomes with a next-generation left atrial appendage device: final results of the PINNACLE FLX Trial","volume":"12","author":"Doshi","year":"2023","journal-title":"J Am Heart Assoc"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X24010351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X24010351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T07:33:22Z","timestamp":1777707202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X24010351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2405500X24010351"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2024.12.013","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Causal Machine Learning for Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2024.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}